GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would ...

Relation has announced two strategic collaborations with GSK, focusing on the discovery and validation of therapeutics that target fibrotic diseases and osteoarthritis. Relation will obtain a $45m ...

Relation Therapeutics and GSK signed two contracts to discover and develop new therapeutic targets to treat osteoarthritis and fibrotic disease. The U.K. biotech will receive a total upfront ...

London, UK, December 10, 2024 – Relation, an industry leader in deploying computation and experimentation to drug discovery, today announced two multi-program strategic collaborations with GSK. The ...

Mishcon de Reya has provided critical legal support to Relation, a leading biotechnology company, in establishing two significant strategic collaborations with GSK. These agreements focus on the ...

Stocks in London are set to open lower on Tuesday, with a eurozone inflation reading, and US data in focus. Both batches of data will be scrutinised for what they could mean for the European Central ...